Clozapine Nursing Care Plan
Clozapine Nursing Care Plan
Prepared by: [YOUR NAME]
Email: [YOUR EMAIL]
Date: January 1, 2050
Patient Details
|
Field |
Details |
|---|---|
|
Patient Name |
John Casper |
|
Age |
35 |
|
Gender |
Male |
|
Diagnosis |
Treatment-Resistant Schizophrenia |
|
Medication |
Clozapine 300 mg/day |
|
Plan Start Date |
January 1, 2050 |
|
Plan Review Date |
April 1, 2050 |
Nursing Diagnosis and Goals
|
Nursing Diagnosis |
Goals |
|---|---|
|
Risk of infection related to agranulocytosis secondary to clozapine |
Ensure patient maintains an absolute neutrophil count (ANC) above 1,500/mm³. |
|
Non-adherence to medication regimen |
Patient will demonstrate consistent adherence to medication by March 1, 2050. |
|
Risk of weight gain and metabolic syndrome due to medication |
Limit weight gain to no more than 5% of baseline weight within three months. |
Interventions and Rationales
|
Intervention |
Rationale |
Expected Outcome |
|---|---|---|
|
Educate the patient on the importance of routine blood tests (weekly for the first six months, then biweekly). |
Early detection of agranulocytosis is critical to prevent complications. |
Patient completes 100% of scheduled blood tests by the next review date. |
|
Encourage a low-calorie, nutrient-dense diet and regular physical activity. |
Mitigates weight gain and reduces the risk of metabolic syndrome. |
Patient engages in at least 30 minutes of exercise, 3 times a week. |
|
Monitor for side effects such as sedation, hypotension, or signs of infection (e.g., fever, sore throat). |
Early identification of adverse effects ensures timely intervention. |
Patient remains free from infections and severe side effects by review date. |
Monitoring and Documentation
|
Parameter |
Frequency |
Notes |
|---|---|---|
|
ANC (Absolute Neutrophil Count) |
Weekly for 6 months, biweekly thereafter |
Ensure results are communicated promptly to the healthcare provider. |
|
Weight and BMI |
Monthly |
Monitor trends and adjust dietary/exercise interventions as needed. |
|
Blood Pressure |
Every visit (biweekly) |
Watch for orthostatic hypotension and adjust medication if required. |
Patient and Caregiver Education Plan
|
Topic |
Details |
|---|---|
|
Purpose of clozapine |
Explain how clozapine helps manage treatment-resistant schizophrenia. |
|
Signs of potential side effects to report |
Educate on symptoms like fever, extreme fatigue, or sore throat. |
|
Importance of adherence and follow-ups |
Stress the importance of taking medication and attending scheduled check-ups. |
Evaluation
|
Criteria |
Date |
Evaluation Outcome |
|---|---|---|
|
ANC within normal limits |
February 1, 2050 |
Achieved. No signs of agranulocytosis. |
|
Patient adhering to medication regimen |
March 1, 2050 |
On track. Patient reports no missed doses. |
|
Weight gain controlled |
April 1, 2050 |
Partially achieved. Weight gain <5% from baseline. |
